Categories: Market News

Boeing ends objection to United Tech and Rockwell mega-deal

United Technologies (UTX) and Rockwell Collins (COL) are inching toward an accord for the biggest-ever merger in the aerospace industry, with Boeing (BA) withdrawing its objection. Surprisingly, there are hardly any regulatory obstacles to this merger. The deal didn’t stumble on any antitrust issues. But it did disturb Boeing and European rival Airbus, both voicing their opinion against the mega-deal stating that it would damage competition.

 This is not the first that Boeing and Airbus have been against a potential merger in its sector. Both companies displayed a similar disagreement when Honeywell and United Tech were musing on a deal.

(Image Courtesy: Wikimedia Commons)

The two giants were tough on this new merger as well. Boeing even threatened to end some of its contracts with United Tech’s UTC aerospace system division and Rockwell — Boeing’s major suppliers of avionic systems — as the union of the two companies could cut competition within the supply chain. Many have pointed out that the potential merger would hit Boeing’s in-house supplier Boeing Avionics, dragging it into the competition.

But all that is in the past now, with Boeing giving its thumbs up on United Tech and Rockwell’s mega-deal. The aircraft giant changed its statements after it reached an agreement with the two suppliers to help assist the company’s cost-cutting initiative.

Share
Published by

Recent Posts

Aramark Holdings Q1 Revenue Tops Estimates; Shares Mixed After Close

Aramark Holdings Corp (NYSE: ARMK) shares closed at about $38.77 on Monday, marking a modest…

9 minutes ago

S&P Global (SPGI) reports double-digit growth in Q4 adj. earnings; revenue up 9%

S&P Global (NYSE: SPGI), a leading provider of financial intelligence solutions, reported strong earnings growth…

33 minutes ago

Fiserv (FISV) Earnings: 4Q25 Key Numbers

Fiserv Inc. (NASDAQ: FISV) reported its fourth quarter 2025 earnings results today. Revenue increased 1%…

47 minutes ago

Incyte Corporation Reports Strong 2025 Fiscal Results and Provides 2026 Guidance

Incyte achieved total revenue of $5.14 billion for the full year 2025, a 21% year-over-year…

49 minutes ago

CVS Health Reports Record 2025 Revenue of $402.1 Billion and Reaffirms 2026 Earnings Guidance

CVS Health Corporation (NYSE: CVS) reported record full-year 2025 consolidated revenues of $402.1 billion, a…

1 hour ago

CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline

Healthcare solutions company CVS Health Corporation (NYSE: CVS) on Monday reported an increase in revenues…

1 hour ago